Episode 22: Aussie growth stocks for the next decade? Mike and Claude talk Polynovo, Avita, Audinate, Pro Medicus and Afterpay

Mike and Claude from A Rich Life (https://arichlife.com.au/) talk Australian growth stocks for the next decade.  If you'd like to know more about us see: www.fraziscapitalpartners.com 0:38 - Claude's background and time at Motley Fool 4:30 - Pro Medicus (PME:ASX) recommendation and discussion 6:38 - Claude touches on his investment style 8:08 - Pro Medicus as a platform business rather than just a software business 8:30 - Pro Medicus - the numbers 10:20 - Claude dives into Pro Medicus' two key revenue streams 11:50 - Michael introduces Alteryx (AYX:NYSE) and accounting standards 14:45 - Claude's worst mistake (Touchcorp) 17:30 - Claude touches on cognitive errors 18:10 - Michael discusses Afterpay (APT:ASX), comparing it to some US tech investments 19:25 - Afterpay, the YOLO stock? 21:55 - The network effects of Afterpay 22:30 - Consumer behaviour of Afterpay customers 24:38 - Claude introduces Avita Healthcare (AVH:ASX), discussed in Frazis Capital's previous podcast 26:58 - Avita's opportunity in vitiligo and skin rejuvenation 29:59 - How to value a company like Avita when there are no conventional cashflows? 32:02 - When should you sell a company like Avita? 35:20 - BARDA's funding of Polynovo (PNV:ASX) and Avita 37:40 - Claude goes through Audinate (AD8:ASX) 41:55 - Audinate's financial numbers 45:00 - Audinate's next 5 years 48:00 - Claude talks about his new project, "A Rich Life"